shorelinebio.comHealthcare / BioTech & PharmaFounded: 2020Funding to Date: $186MM
Shoreline Biosciences is a biotechnology company focused on immunotherapies for patients who are ill. Their core focus is on induced Pluripotent Stem Cells (iPSCs) and Macrophages (iMACs) which aim to target tumor and cancer cells. Shoreline Biosciences was founded in 2020 by Dan Kaufman, Kleanthis Xanthopoulos Ph.D, and Steven Holtzman and is headquartered in San Diego, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/02/2021 | Series B | $140MM | $xx.xx | $527.99MM | Ally Bridge Group, Eventide Asset Management, BeiGene, Irving Investors, Kingdon, NS Investment, Piper Heartland Healthcare Capital, Superstring, BVF Partners, Commodore Capital, Cormorant Asset Management, Janus Henderson Investors, Kite, Stork Capital, Wedbush Healthcare Partners | |
Price per Share
$xx.xx
Shares Outstanding
13,906,282
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Ally Bridge Group, Eventide Asset Management, BeiGene, Irving Investors, Kingdon, NS Investment, Piper Heartland Healthcare Capital, Superstring, BVF Partners, Commodore Capital, Cormorant Asset Management, Janus Henderson Investors, Kite, Stork Capital, Wedbush Healthcare Partners
|
||||||
02/07/2021 | Series A | $43MM | $xx.xx | $87.56MM | Boxer Capital | |
Price per Share
$xx.xx
Shares Outstanding
18,545,675
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Boxer Capital
|
||||||
07/17/2020 | Series Seed | $3MM | $xx.xx | $8.57MM | Stork Capital | |
Price per Share
$xx.xx
Shares Outstanding
6,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Stork Capital
|